Literature DB >> 26984559

Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy.

Nobuhiro Suzumori1,2, Takeshi Ebara3, Takahiro Yamada1,4, Osamu Samura1,5, Junko Yotsumoto1,6, Miyuki Nishiyama1,7, Kiyonori Miura1,8, Hideaki Sawai1,9, Jun Murotsuki1,10, Michihiro Kitagawa1,11, Yoshimasa Kamei1,12, Hideaki Masuzaki1,8, Fumiki Hirahara1,13, Juan-Sebastian Saldivar14, Nilesh Dharajiya14, Haruhiko Sago1,7, Akihiko Sekizawa1,15.   

Abstract

The purpose of this noninvasive prenatal testing (NIPT) study was to compare the fetal fraction of singleton gestations by gestational age, maternal characteristics and chromosome-specific aneuploidies as indicated by z-scores. This study was a multicenter prospective cohort study. Test data were collected from women who underwent NIPT by the massively parallel sequencing method. We used sequencing-based fetal fraction calculations in which we estimated fetal DNA fraction by simply counting the number of reads aligned within specific autosomal regions and applying a weighting scheme derived from a multivariate model. Relationships between fetal fractions and gestational age, maternal weight and height, and z-scores for chromosomes 21, 18 and 13 were assessed. A total of 7740 pregnant women enrolled in the study, of which 6993 met the study criteria. As expected, fetal fraction was inversely correlated with maternal weight (P<0.001). The median fetal fraction of samples with euploid result (n=6850) and trisomy 21 (n=70) were 13.7% and 13.6%, respectively. In contrast, the median fetal fraction values for samples with trisomies 18 (n=35) and 13 (n=9) were 11.0% and 8.0%, respectively. The fetal fraction of samples with trisomy 21 NIPT result is comparable to that of samples with euploid result. However, the fetal fractions of samples with trisomies 13 and 18 are significantly lower compared with that of euploid result. We conclude that it may make detecting these two trisomies more challenging.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26984559     DOI: 10.1038/jhg.2016.25

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  20 in total

Review 1.  Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation?

Authors:  S Hahn; B Huppertz; W Holzgreve
Journal:  Placenta       Date:  2004-12-23       Impact factor: 3.481

2.  Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.

Authors:  Richard P Porreco; Thomas J Garite; Kimberly Maurel; Barbara Marusiak; Mathias Ehrich; Dirk van den Boom; Cosmin Deciu; Allan Bombard
Journal:  Am J Obstet Gynecol       Date:  2014-03-19       Impact factor: 8.661

Review 3.  Turning the pyramid of prenatal care.

Authors:  Kypros H Nicolaides
Journal:  Fetal Diagn Ther       Date:  2011-03-08       Impact factor: 2.587

4.  Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

Authors:  Diana W Bianchi; Lawrence D Platt; James D Goldberg; Alfred Z Abuhamad; Amy J Sehnert; Richard P Rava
Journal:  Obstet Gynecol       Date:  2012-05       Impact factor: 7.661

5.  Noninvasive prenatal testing: the paradigm is shifting rapidly.

Authors:  Lyn S Chitty; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2013-06       Impact factor: 3.050

Review 6.  Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?

Authors:  Diana W Bianchi; Louise Wilkins-Haug
Journal:  Clin Chem       Date:  2013-11-19       Impact factor: 8.327

7.  Non-specific psychological distress in women undergoing noninvasive prenatal testing because of advanced maternal age.

Authors:  Nobuhiro Suzumori; Takeshi Ebara; Kyoko Kumagai; Shinobu Goto; Yasuyuki Yamada; Michihiro Kamijima; Mayumi Sugiura-Ogasawara
Journal:  Prenat Diagn       Date:  2014-06-29       Impact factor: 3.050

8.  DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.

Authors:  Glenn E Palomaki; Cosmin Deciu; Edward M Kloza; Geralyn M Lambert-Messerlian; James E Haddow; Louis M Neveux; Mathias Ehrich; Dirk van den Boom; Allan T Bombard; Wayne W Grody; Stanley F Nelson; Jacob A Canick
Journal:  Genet Med       Date:  2012-02-02       Impact factor: 8.822

9.  The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy.

Authors:  Herb Brar; Eric Wang; Craig Struble; Thomas J Musci; Mary E Norton
Journal:  J Matern Fetal Neonatal Med       Date:  2012-09-12

10.  Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women.

Authors:  Maricela Haghiac; Neeta L Vora; Subhabrata Basu; Kirby L Johnson; Larraine Presley; Diana W Bianchi; Sylvie Hauguel-de Mouzon
Journal:  Obesity (Silver Spring)       Date:  2012-06-07       Impact factor: 5.002

View more
  14 in total

1.  Assessing aneuploidy with repetitive element sequencing.

Authors:  Christopher Douville; Joshua D Cohen; Janine Ptak; Maria Popoli; Joy Schaefer; Natalie Silliman; Lisa Dobbyn; Robert E Schoen; Jeanne Tie; Peter Gibbs; Michael Goggins; Christopher L Wolfgang; Tian-Li Wang; Ie-Ming Shih; Rachel Karchin; Anne Marie Lennon; Ralph H Hruban; Cristian Tomasetti; Chetan Bettegowda; Kenneth W Kinzler; Nickolas Papadopoulos; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205

2.  Fetal fraction evaluation in non-invasive prenatal screening (NIPS).

Authors:  Matthew S Hestand; Mark Bessem; Peter van Rijn; Renee X de Menezes; Daoud Sie; Ingrid Bakker; Elles M J Boon; Erik A Sistermans; Marjan M Weiss
Journal:  Eur J Hum Genet       Date:  2018-09-25       Impact factor: 4.246

3.  Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.

Authors:  Jaime L Lopes; Guilherme S Lopes; Elizabeth A L Enninga; Hutton M Kearney; Nicole L Hoppman; Ross A Rowsey
Journal:  Prenat Diagn       Date:  2020-04-20       Impact factor: 3.050

4.  Triploidy in a Live-Born Extremely Low Birth Weight Twin: Clinical Aspects.

Authors:  Liliya Vakrilova; Stanislava Hitrova-Nikolova; Irena Bradinova
Journal:  J Pediatr Genet       Date:  2020-09-23

5.  Chromosomal phase improves aneuploidy detection in non-invasive prenatal testing at low fetal DNA fractions.

Authors:  Giulio Genovese; Curtis J Mello; Po-Ru Loh; Robert E Handsaker; Seva Kashin; Christopher W Whelan; Lucy A Bayer-Zwirello; Steven A McCarroll
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

6.  Study of Relationship Between Mode of Conception and Non-Specific Psychological Distress in Women Undergoing Noninvasive Prenatal Testing.

Authors:  Nobuhiro Suzumori; Eri Takeda; Takeshi Ebara; Kyoko Kumagai; Yuki Sawada; Mayumi Sugiura-Ogasawara
Journal:  J Reprod Infertil       Date:  2020 Jul-Sep

Review 7.  Prenatal Diagnosis: Screening and Diagnostic Tools.

Authors:  Laura M Carlson; Neeta L Vora
Journal:  Obstet Gynecol Clin North Am       Date:  2017-06       Impact factor: 2.844

8.  A case of Ewing's sarcoma identified via noninvasive prenatal testing.

Authors:  Keiko Miyagami; Ryu Matsuoka; Mayumi Tokunaka; Nahoko Shirato; Mikiko Izumi; Tatsuko Hirose; Akihiko Sekizawa
Journal:  Clin Case Rep       Date:  2020-03-14

9.  Follow-up in Patients With Non-invasive Prenatal Screening Failures: A Reflection on the Choice of Further Prenatal Diagnosis.

Authors:  Sha Liu; Hongqian Liu; Jianlong Liu; Ting Bai; Xiaosha Jing; Tianyu Xia; Cechuan Deng; Yunyun Liu; Jing Cheng; Xiang Wei; Lingling Xing; Yuan Luo; Quanfang Zhou; Qian Zhu
Journal:  Front Genet       Date:  2021-05-19       Impact factor: 4.599

10.  The Level of Free Fetal DNA as Precise Noninvasive Marker for Chromosomal Aneuploidies: First Results from BALTIC Region.

Authors:  Danielius Serapinas; Evelina Boreikaitė; Agnė Bartkevičiūtė; Kristina Norvilaitė; Andrius Narbekovas; Daiva Bartkevičienė
Journal:  Medicina (Kaunas)       Date:  2020-10-30       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.